diabetic foot ulcer
It also incorporates gamification to encourage self-health monitoring.
The FootSense monitoring device spots changes in temperatures between a person's feet which may indicate complications.
Along with funds announced a few months back, this brings the round's total to $20.8 million.
The company's diabetic foot ulcer detection platform is now available through 40 VA medical centers.
The round now comes to a total of $16.55 million, and will continue to support the company's push into the VA and commercial payer markets.
The technology proved its merit in a pilot that reported high detection rates and adherence, and is already in use at 15 VA medical centers.
The company will be using the funds to expand its business with the VA and other commercial payers.
Sensors connected via Bluetooth to a smartphone app can provide users frequent reports on their foot's temperature.
The SurroSense Rx system will be available to Onduo's members in 2019.